Agentic AI is transforming healthcare delivery — what does that mean for pharma?
Moving from static tools to intelligent systems that proactively support clinical decisions, coordinate care, and adapt in real time. With the right collaborators, pharma can shift its lens from seeing this as disruptive to opportunity.
This report, based on insights from Viz.ai’s most recent AI Vizionaries Summit, explores how pharma leaders can play a central role in building this future. It outlines how pharma can go beyond traditional engagement to become a co-creator of AI-powered care delivery—embedding therapies into clinical workflows, generating real-time insights, and driving measurable impact across the patient journey.
Download the full report to explore:
- Why pharma’s current commercial model is losing relevance as AI becomes the new infrastructure guiding real-time treatment decisions.
- How HCPs are rapidly adopting and trusting AI, with usage nearly doubling in 2024 alone—reshaping expectations around data, engagement, and support.
- What it will take to lead in this new landscape: integrated solutions, clinical collaboration, and a willingness to co-build the future of care.
